Teacher Retirement System of Texas Buys 47,472 Shares of Alignment Healthcare, Inc. $ALHC

Teacher Retirement System of Texas increased its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 85.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 102,827 shares of the company’s stock after acquiring an additional 47,472 shares during the quarter. Teacher Retirement System of Texas owned about 0.05% of Alignment Healthcare worth $1,794,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Olympiad Research LP bought a new position in shares of Alignment Healthcare during the 3rd quarter valued at about $357,000. Universal Beteiligungs und Servicegesellschaft mbH boosted its stake in Alignment Healthcare by 2.3% during the third quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 37,752 shares of the company’s stock valued at $659,000 after buying an additional 844 shares during the last quarter. Wealth Enhancement Advisory Services LLC purchased a new position in Alignment Healthcare during the 3rd quarter valued at approximately $281,000. Yorktown Management & Research Co Inc bought a new stake in Alignment Healthcare in the 3rd quarter worth approximately $215,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in shares of Alignment Healthcare during the 3rd quarter worth approximately $53,000. 86.19% of the stock is currently owned by institutional investors.

Insider Activity

In related news, insider Christopher J. Joyce sold 10,611 shares of the firm’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $20.03, for a total value of $212,538.33. Following the transaction, the insider owned 297,088 shares of the company’s stock, valued at $5,950,672.64. This trade represents a 3.45% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction dated Thursday, January 15th. The shares were sold at an average price of $22.48, for a total transaction of $674,400.00. Following the completion of the sale, the president directly owned 1,027,015 shares of the company’s stock, valued at approximately $23,087,297.20. This trade represents a 2.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 2,103,532 shares of company stock valued at $40,529,538. Insiders own 7.00% of the company’s stock.

Alignment Healthcare Stock Up 0.1%

Shares of NASDAQ:ALHC opened at $22.53 on Friday. The firm has a market capitalization of $4.51 billion, a PE ratio of -187.75, a price-to-earnings-growth ratio of 5.92 and a beta of 1.16. The business has a 50 day simple moving average of $20.48 and a two-hundred day simple moving average of $17.45. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The firm had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.Alignment Healthcare’s quarterly revenue was up 43.5% compared to the same quarter last year. During the same period last year, the company earned ($0.14) EPS. On average, equities analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently weighed in on ALHC. TD Cowen boosted their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a research report on Friday, January 16th. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. The Goldman Sachs Group restated a “buy” rating and set a $22.00 target price on shares of Alignment Healthcare in a research report on Monday, November 3rd. Zacks Research lowered Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 28th. Finally, KeyCorp restated an “overweight” rating and set a $28.00 price objective on shares of Alignment Healthcare in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $23.05.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.